MIRM Message Board Post 9977390 | Mirum Pharmaceuticals...
home / stock / mirm / mirm message board
John
(investorshub)
Posted on: Dec/18/2019 17:53:24
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152865137
Nice
News, Short Squeeze, Breakout and More Instantly...
Mirum Pharmaceuticals Inc. Company Name:
MIRM Stock Symbol:
Market:
-
- First quarter 2024 total revenue of $69.2 million, on track to achieve full-year guidance of $310 to $320 million - FDA approval of LIVMARLI for cholestatic pruritus in PFIC patients achieved in March - Volixibat VISTAS and VANTAGE interim analyses scheduled for June of 2024 - Cash balanc...
-
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
-
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will present at the Citizens JMP Life Sciences Conference in ...